Bayview Pharmacy's Lidocaine 2%/Diclofenac Sodium 3%/Cyclobenzaprine HCl 2%/Baclofen 2% Topical Gel is a semisolid formulation. It is dispensed through a pump mechanism for easy and precise application on the skin. This compounded medication is used for targeted treatment of neuropathic pain, fibromyalgia, muscle spasms, sciatica, and tendonitis. The gel-like consistency aids in the absorption of active ingredients.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present a specialized topical gel formulation that combines lidocaine 2%, diclofenac sodium 3%, cyclobenzaprine HCl 2%, and baclofen 2%. This unique blend is specifically designed to alleviate a range of painful conditions, such as neuropathic pain, fibromyalgia, muscle spasms, sciatica, and tendonitis.
Lidocaine, a local anesthetic, functions by blocking nerve signals in the area of discomfort, thereby providing pain relief. Diclofenac sodium, a non-steroidal anti-inflammatory drug (NSAID), operates by reducing inflammation and pain. Cyclobenzaprine HCl, a muscle relaxant, works by blocking nerve impulses that trigger muscle spasms. Baclofen, another muscle relaxant, functions by reducing muscle spasms and associated pain.
This compounded formulation is dispensed as a semisolid through a pump mechanism, which allows for easy and precise application on the skin. The gel-like consistency ensures targeted treatment or absorption of the active ingredients.
It is crucial to remember that this formulation should only be used as directed by a healthcare provider. If you have any queries about this formulation or how it can assist in treating your condition, please do not hesitate to contact us at Bayview Pharmacy. We are committed to providing comprehensive information and guidance on our products to ensure optimal patient care and satisfaction.
This compounded formulation of Lidocaine 2%/Diclofenac Sodium 3%/Cyclobenzaprine HCl 2%/Baclofen 2% Topical Gel is a semisolid preparation designed for targeted treatment of various pain conditions. It is dispensed through a pump mechanism, which allows for easy and precise application on the skin.
The formulation contains four active ingredients: Lidocaine, Diclofenac Sodium, Cyclobenzaprine HCl, and Baclofen. Lidocaine is a local anesthetic that works by blocking nerve signals to reduce pain. Diclofenac Sodium is a nonsteroidal anti-inflammatory drug (NSAID) that helps to alleviate inflammation and pain. Cyclobenzaprine HCl and Baclofen are muscle relaxants that work to reduce muscle spasms and pain.
This topical gel is indicated for the treatment of neuropathic pain, fibromyalgia, muscle spasms, sciatica, and tendonitis. It may be used to reduce pain, inflammation, and muscle spasms associated with these conditions.
Patients should apply the topical gel to the affected area as directed by their healthcare provider. It should not be applied to broken or damaged skin, or to areas of the body other than the affected area. Overuse or prolonged use beyond the prescribed duration is not recommended.
Before using this formulation, patients should inform their healthcare provider if they are pregnant, breastfeeding, or planning to become pregnant. They should also disclose any other medications they are taking, including over-the-counter medications, vitamins, and herbal supplements, as well as any allergies or medical conditions they have.
While using this formulation, patients should monitor for any side effects such as skin irritation, redness, itching, burning, or swelling. Serious side effects, including difficulty breathing, rash, hives, or swelling of the face, lips, tongue, or throat, require immediate medical attention.
If you have any questions about this formulation or potential interactions with other medications, please consult with your healthcare provider or pharmacist.
Lidocaine 2%/Diclofenac Sodium 3%/Cyclobenzaprine HCl 2%/Baclofen 2% Topical Gel is a compounded formulation that combines four potent active ingredients, each with a unique role in providing relief from various conditions. This topical gel is designed to be applied directly to the skin, targeting the affected area for optimal therapeutic effect.
Lidocaine, a local anesthetic, works by numbing the skin and surrounding tissues, thereby reducing pain and inflammation. Diclofenac Sodium, a non-steroidal anti-inflammatory drug (NSAID), further aids in reducing inflammation and pain. Cyclobenzaprine HCl and Baclofen, both muscle relaxants, work in tandem to alleviate muscle spasms and associated pain.
When using this topical gel, it is crucial to adhere to the directions provided by your healthcare provider. Typically, the gel should be applied to the affected area two to three times daily. Always ensure to wash your hands before and after application to maintain hygiene and prevent potential contamination. Avoid applying the gel on broken or irritated skin to prevent exacerbation of the condition or potential side effects.
Side effects such as skin irritation, redness, or itching may occur. If you experience any of these or other adverse reactions, discontinue use immediately and consult your healthcare provider. It is always important to monitor your body's response to a new medication and report any unusual symptoms promptly.
If you have any queries or concerns about using Lidocaine 2%/Diclofenac Sodium 3%/Cyclobenzaprine HCl 2%/Baclofen 2% Topical Gel for your condition, do not hesitate to seek advice from your healthcare provider. They can provide you with the most accurate and personalized information based on your specific health status and needs.
This compounded formulation of Lidocaine 2%, Diclofenac Sodium 3%, Cyclobenzaprine HCl 2%, and Baclofen 2% in a topical gel form is a targeted treatment designed for direct application on the skin. It has been effectively used in the management of various pain conditions including neuropathic pain, fibromyalgia, muscle spasms, sciatica, and tendonitis. It has also shown efficacy in treating chronic low back pain, myofascial pain syndrome, and post-herpetic neuralgia.
The gel is dispensed through a pump mechanism, which allows for easy and precise application. The active ingredients are absorbed through the skin, directly targeting the affected area. It is crucial to remember that this formulation should not be applied to open wounds or areas of skin that are broken or irritated. Prolonged use of more than two weeks is not recommended without consulting a healthcare professional.
Patients should be aware that this formulation may cause skin irritation, redness, or a burning sensation at the application site. If any of these side effects occur, it is recommended to discontinue use and consult with a healthcare provider. This formulation is a testament to the advancements in topical pain management, offering targeted relief with minimal systemic side effects.
This is a compounded formulation of four active ingredients: Lidocaine, Diclofenac Sodium, Cyclobenzaprine HCl, and Baclofen. It is a semisolid formulation dispensed through a pump mechanism for easy and precise application on the skin.
This formulation is designed for targeted treatment or absorption of the active ingredients. It is typically used for pain relief and muscle relaxation.
You apply the gel to the affected area as directed by your healthcare provider. The pump mechanism allows for easy and precise application.
The gel has a semisolid, gel-like consistency which allows it to be easily spread on the skin.
It is generally safe for use on most parts of the body, but it should not be applied to broken skin or open wounds. Always follow your healthcare provider's instructions.
The active ingredients are Lidocaine, Diclofenac Sodium, Cyclobenzaprine HCl, and Baclofen.
Side effects can include skin irritation, redness, or itching at the application site. If you experience any severe or persistent side effects, contact your healthcare provider immediately.
Always consult your healthcare provider before using any new medication while pregnant or breastfeeding. They will be able to advise you based on your specific situation and the potential risks and benefits.
Store the gel at room temperature, away from heat and direct light. Do not freeze. Keep out of the reach of children.
If you miss a dose, apply it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not apply extra gel to make up for a missed dose.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)